Medopad, a London-based mobile platform for healthcare companies, insurers, doctors and patients, is working with UBS Group to raise $30m from private investors. The company has raised $321m in venture capital funding so far this year, including an investment of $53m by the US government last year. Medopad already has support from Bayer AG and has expanded into Germany and the US.
Medopad, a London-based mobile platform for healthcare companies, insurers, doctors and patients, is working with UBS Group to raise $30m from private investors. The new funds will be used to expand Medopad’s analytics and machine learning teams. Medopad already has support from Bayer AG and has expanded into Germany and the US.